Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 3 IN DEXTROSE 5 AND SODIUM CHLORIDE 0 9 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 3 IN DEXTROSE 5 AND SODIUM CHLORIDE 0 9 IN PLASTIC CONTAINER.
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER vs POTASSIUM CHLORIDE 0.3% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
Potassium chloride (KCl) replaces potassium ions lost from the body and is essential for nerve conduction, muscle contraction, and maintenance of intracellular tonicity. Dextrose provides caloric support, and sodium chloride restores sodium and chloride deficits.
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
Intravenous infusion; adult: 1000-2000 mL/day (providing 3 g NaCl, 50 g dextrose, and 30 mEq K+ per 1000 mL) at a rate determined by fluid and electrolyte needs, typically 0.5-1 mEq/kg/hr potassium; not to exceed 10 mEq/hr potassium without continuous cardiac monitoring.
None Documented
None Documented
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Potassium chloride: not applicable as a single half-life; plasma potassium is tightly regulated. Sodium chloride: no defined half-life; sodium and chloride are distributed and excreted according to homeostasis. Dextrose: rapid, with a half-life of 15-30 minutes for glucose in normal individuals.
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Potassium chloride: primarily renal (90% excreted in urine, with minimal fecal loss). Sodium chloride: renal excretion accounts for >95% of eliminated sodium and chloride. Dextrose: completely metabolized to CO2 and water; no significant renal excretion.
Category C
Category A/B
Electrolyte
Electrolyte